Leukemia inhibitory factor (LIF) is a glycoprotein, classified as a sub-class of interleukin 6 cytokines with a wide biological function range and multiple effects on cells, human physiology and disease [
1]. It was first characterized as an inducer of macrophage differentiation while it inhibits the growth of murine myeloid leukemia M1 cells. Also it regulates the survival of neurons, hematopoiesis, differentiation in embryonic stem cells, motility and survival rate of sperm, platelet numbers by effecting bone marrow function, improves survival of both sensory and motor neurons acute phase proteins embryo development [
2-
12]. HLIF is absolutely required for maintaining the stemness of embryonic stem cell (ESC) lines [
13-
16]. LIF-deficient mice demonstrate difficulties in blastocyst implantation [
17], which suggests that administration of hLIF may aid the implantation rate of women displaying some forms of infertility [
18]. The tyrosine kinase [Janus kinas (JAK)] binds constitutively to the intercellular domain of the LIF receptor complex in its inactive form. Upon LIF binding, JAK kinase activates transcription of signal transducers and activators of transcription (STAT) 1 and STAT 3 through SH2 domains. STAT proteins are then activated and translocated in to the nucleus, where they function as transcription factors [
19,
20]. CISH gene encodes a protein which contains a SH2 domain and a SOCS box domain. These proteins belong to cytokine-induced STAT inhibitor (CIS) that are suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family. CIS family members are known to be cytokine-inducible negative regulators of cytokine signaling. According to CISH Inducibility by LIF pathway, we choose it for treatment with homemade his 6-LIF to evaluate LIF bioactivity. Low expression of LIF in eukaryotic cells has been reported [
3,
21].
Escherichia coli (
E. coli) has higher expression, however the protein mis-folds and aggregates to form inclusion bodies (IBs) in prokaryotic hosts is common [
22]. In general, the solubilization of IBs requires high concentrations of denaturants, such as urea or guanidine hydrochloride and subsequent refolding via the removal of the denaturants. In many cases the overall yield of biologically active protein from IBs is low [
23].